Publications

  1. Csizmar CM, Saliba AN, Greipp PT, Alkhateeb H, Begna KH, Foran JM, Gangat N, Hogan WJ, Hook CC, Litzow MR, Mangaonkar AA, Palmer JM, Pardanani A, Shah MV, Tefferi A, Torghabeh MH, Wolanskyj-Spinner AP, Patnaik MM, Kaufmann SH, Al-Kali A. FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214): the Mayo Clinic experience. Haematologica. 2024 Nov 1; 109 (11):3785-3789 Epub 2024 Nov 01
    View PubMed
  2. Farrukh F, Abdelmagid M, Mangaonkar A, Patnaik M, Al-Kali A, Elliott MA, Begna KH, Hook CC, Hogan WJ, Pardanani A, Litzow MR, Ketterling RP, Gangat N, Arber DA, Orazi A, He R, Reichard K, Tefferi A. Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases. Haematologica. 2024 Aug 1; 109 (8):2525-2532 Epub 2024 Aug 01
    View PubMed
  3. Nathoo N, Uhm JH, Porter AB, Hammack J, Jaeckle KA, Mrugala MM, Crum BA, Flanagan EP, Pittock SJ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Bach C, Ravindran A, Sartori Valinotti JC, Bennani NN, Abeykoon JP, Shah MV, Hook CC, Rech KL, Go RS, Tobin WO, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Clinical features and outcomes in primary nervous system histiocytic neoplasms. Blood Cancer J 2024 Jun 20; 14 (1):101 Epub 2024 June 20
    View PubMed
  4. Perera ND, Lakshman A, Hook CC. 61-Year-Old Woman With Bleeding, Bruising, and Myalgias. Mayo Clin Proc. 2023 Sep; 98 (9):1398-1403
    View PubMed
  5. Benson JC, Vaubel R, Ebne BA, Mark IT, Peris Celda M, Hook CC, Tobin WO, Giannini C. Erdheim-Chester Disease. AJNR Am J Neuroradiol. 2023 May; 44 (5):505-510 Epub 2023 Mar 30
    View PubMed
  6. Tefferi A, Singh A, Gangat N, Al-Kali A, Alkhateeb H, Shah M, Patnaik MS, Elliott MA, Hogan WJ, Litzow MR, Wolanskyj-Spinner A, Hook CC, Mangaonkar A, Viswanatha D, Chen D, Pardanani A, Begna KH, Ketterling RP. Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival. Haematologica 2023 Jan 1; 108 (1):245-249 Epub 2023 Jan 01
    View PubMed
  7. Tefferi A, Gangat N, Shah M, Alkhateeb H, Patnaik MS, Al-Kali A, Elliott MA, Hogan WJ, Litzow MR, Hook CC, Mangaonkar A, Viswanatha D, Chen D, Pardanani A, Ketterling RP, Begna KH. Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience. Haematologica. 2022 Oct 1; 107 (10):2474-2479 Epub 2022 Oct 01
    View PubMed
  8. Tefferi A, Gangat N, Al-Kali A, Alkhateeb H, Shah M, Patnaik MS, Elliott MA, Hogan WJ, Litzow MR, Hook CC, Mangaonkar A, Viswanatha D, Chen D, Pardanani A, Ketterling RP, DiNardo CD, Kadia TM, Ravandi F, Sasaki K, Begna KH. A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy. Am J Hematol. 2022 Sep; 97 (9):1127-1134 Epub 2022 June 30
    View PubMed
  9. Farrukh F, Chetram D, Al-Kali A, Foran J, Patnaik M, Badar T, Begna K, Hook C, Hogan W, McCullough KB, Mangaonkar A, He R, Gangat N, Tefferi A. Real-world experience with luspatercept and predictors of response in myelodysplastic syndromes with ring sideroblasts. Am J Hematol 2022 Jun 1; 97 (6):E210-E214 Epub 2022 Mar 29
    View PubMed
  10. Begna KH, Xu X, Gangat N, Alkhateeb H, Patnaik MM, Al-Kali A, Elliott MA, Hogan WJ, Litzow MR, Hook CC, Wolanskyj-Spinner AP, Mangaonkar A, He R, Pardanani A, Shah M, Ketterling RP, Tefferi A. Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3". Blood Cancer J 2022 Apr 7; 12 (4):55 Epub 2022 Apr 07
    View PubMed
  11. Begna KH, Kittur J, Yui J, Gangat N, Patnaik MM, Al-Kali A, Elliott MA, Hogan WJ, Litzow MR, Hook CC, Wolanskyj AP, Howard MT, Hanson CA, Ketterling RP, Pardanani AD, Tefferi A. De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases. Br J Haematol. 2021 Nov; 195 (3):413-416 Epub 2021 Aug 03
    View PubMed
  12. Koster MJ, Kourelis T, Reichard KK, Kermani TA, Beck DB, Cardona DO, Samec MJ, Mangaonkar AA, Begna KH, Hook CC, Oliveira JL, Nasr SH, Tiong BK, Patnaik MM, Burke MM, Michet CJ Jr, Warrington KJ. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series. Mayo Clin Proc. 2021 Oct; 96 (10):2653-2659 Epub 2021 Sept 03
    View PubMed
  13. Goyal G, Abeykoon JP, Hu M, Young JR, Shah MV, Bennani NN, Call TG, Hook CC, Pardanani A, Inwards DJ, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Davidge-Pitts CJ, Ravindran A, Rech KL, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis. Am J Hematol 2021 May 1; 96 (5):E146-E150 Epub 2021 Feb 19
    View PubMed
  14. Liu Q, Major B, Le-Rademacher J, Al-Kali AA, Alkhateeb H, Begna K, Elliott MA, Gangat N, Hogan WJ, Hook CC, Kaufmann SH, Pardanani A, Patnaik MS, Tefferi A, Wolanskyj-Spinner AP, Wei W, Litzow MR. The Impact of Obesity on the Outcomes of Adult Patients with Acute Lymphoblastic Leukemia - A Single Center Retrospective Study. Blood Lymphat Cancer. 2021; 11:1-9 Epub 2021 Jan 22
    View PubMed
  15. Barsness JG, Regnier CR, Hook CC, Mueller PS. US medical and surgical society position statements on physician-assisted suicide and euthanasia: a review. BMC Med Ethics. 2020 Nov 3; 21 (1):111 Epub 2020 Nov 03
    View PubMed
  16. Bubik RJ, Barth DM, Hook C, Wolf RC, Muth JM, Mara K, Patnaik MS, Pruthi RK, Marshall AL, Litzow MR, Elliott MA, Hogan WJ, Shah MV, Begna KH, Alkhateeb H, Pardanani A, Ashrani AA, Call TG, Rivera CE, Camoriano JK, Go RS, Wolanskyj-Spinner AP, Parikh SA. Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis. Leuk Lymphoma. 2020 Jul; 61 (7):1592-1600 Epub 2020 Mar 11
    View PubMed
  17. Hoehner PJ, Beyda DH, Cheshire WP, Cranston RE, Dunlop JT, Francis JE, Mitchell CB, Onarecker C, Riley DJ, Roberts AH, Sullivan DM, Toevs CC, Yates FD, Hook CC. Triage and resource allocation during crisis medical surge conditions (pandemics and mass casualty situations): a position statement of the Christian Medical & Dental Associations Christian Journal for Global Health. 2020; 7(1):45-55.
  18. Azer SM, Eckerman AL, Rodriguez V, Nichols WL Jr, Ashrani AA, Hook CC, Marshall AL, Pruthi RK. Hemostatic prophylaxis and colonoscopy outcomes for patients with bleeding disorders: A retrospective cohort study and review of the literature. Haemophilia. 2020 Mar; 26 (2):257-268 Epub 2020 Mar 06
    View PubMed
  19. Sridharan M, Hook CC, Leung N, Winters JL, Go RS, Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy Disease-Oriented Group. Postsurgical thrombotic microangiopathy: Case series and review of the literature. Eur J Haematol. 2019 Oct; 103 (4):307-318 Epub 2019 July 23
    View PubMed
  20. Hsieh RW, Ravindran A, Hook CC, Begna KH, Ashrani AA, Pruthi RK, Marshall AL, Hogan W, Litzow M, Hoyer J, Oliveira JL, Vishnu P, Call TG, Al-Kali A, Patnaik M, Gangat N, Pardanani A, Tefferi A, Go RS. Etiologies of Extreme Thrombocytosis: A Contemporary Series. Mayo Clin Proc. 2019 Aug; 94 (8):1542-1550
    View PubMed
  21. Sridharan M, Ali U, Hook CC, Nichols WL, Pruthi RK. The Mayo Clinic Experience With Psychogenic Purpura (Gardner-Diamond Syndrome). Am J Med Sci. 2019 May; 357 (5):411-420 Epub 2019 Feb 07
    View PubMed
  22. Szuber N, Mudireddy M, Nicolosi M, Penna D, Vallapureddy RR, Lasho TL, Finke C, Begna KH, Elliott MA, Hook CC, Wolanskyj AP, Patnaik MM, Hanson CA, Ketterling RP, Sirhan S, Pardanani A, Gangat N, Busque L, Tefferi A. 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups. Mayo Clin Proc. 2019 Apr; 94 (4):599-610 Epub 2019 Feb 26
    View PubMed
  23. Tefferi A, Szuber N, Vallapureddy RR, Begna KH, Patnaik MM, Elliott MA, Hook CC, Christopher Hook C, Wolanskyj AP, Hanson CA, Ketterling RP, Pardanani A, Gangat N. Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide. Am J Hematol. 2019 Jan; 94 (1):5-9 Epub 2018 Oct 17
    View PubMed
  24. Begna KH, Ali W, Gangat N, Elliott MA, Al-Kali A, Litzow MR, Hook CC, Wolanskyj AP, Hogan WJ, Patnaik MM, Pardanani A, Zblewski DL, Chen D, He R, Viswanatha D, Hanson CA, Ketterling RP, Tefferi A. A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status. Am J Hematol 2018 Dec; 93 (12):E401-E404 Epub 2018 Oct 17
    View PubMed
  25. Sridharan M, Fylling KA, Ashrani AA, Chen D, Marshall AL, Hook CC, Cardel LK, Nichols WL, Pruthi RK. Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience. Thromb Res. 2018 Nov; 171:14-21 Epub 2018 Sept 05
    View PubMed
  26. Tefferi A, Gangat N, Mudireddy M, Lasho TL, Finke C, Begna KH, Elliott MA, Al-Kali A, Litzow MR, Hook CC, Wolanskyj AP, Hogan WJ, Patnaik MM, Pardanani A, Zblewski DL, He R, Viswanatha D, Hanson CA, Ketterling RP, Tang JL, Chou WC, Lin CC, Tsai CH, Tien HF, Hou HA. Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information. Mayo Clin Proc. 2018 Oct; 93 (10):1363-1374 Epub 2018 June 14
    View PubMed
  27. Goyal G, Shah MV, Hook CC, Wolanskyj AP, Call TG, Rech KL, Go RS. Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long-term outcomes. Br J Haematol 2018 Aug; 182 (4):579-581 Epub 2017 June 27
    View PubMed
  28. Go RS, Winters JL, Leung N, Murray DL, Willrich MA, Abraham RS, Amer H, Hogan WJ, Marshall AL, Sethi S, Tran CL, Chen D, Pruthi RK, Ashrani AA, Fervenza FC, Cramer CH 2nd, Rodriguez V, Wolanskyj AP, Thomé SD, Hook CC, Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy Disease-Oriented Group. Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group. Mayo Clin Proc. 2016 Sep; 91(9):1189-211. Epub 2016 Aug 03.
    View PubMed
  29. Shah MV, Hook CC, Call TG, Go RS. A population-based study of large granular lymphocyte leukemia. Blood Cancer J. 2016 Aug 5; 6 (8):e455 Epub 2016 Aug 05
    View PubMed
  30. Rogers JM, Morris MA, Hook CC, Havyer RD. Introduction to Disability and Health for Preclinical Medical Students: Didactic and Disability Panel Discussion. MedEdPORTAL. 2016 Jul 21; 12:10429 Epub 2016 July 21
    View PubMed
  31. Subari S, Patnaik M, Alfakara D, Zblewski D, Hook C, Hashmi S, Hogan W, Litzow M, Al-Kali A. Hypomethylating agents are effective in shrinking splenomegaly in patients with chronic myelomonocytic leukemia. Leuk Lymphoma 2016 Jul; 57 (7):1714-5 Epub 2016 Mar 14
    View PubMed
  32. McCall AN, Ingimarsson JP, Morrisson GT, Hook CC, Krambeck AE. Successful Percutaneous Nephrolithotomy in Patients with Immune-Mediated Thrombocytopenia Treated with Romiplostim. J Endourol Case Rep. 2016; 2 (1):81-3 Epub 2016 Apr 01
    View PubMed
  33. Rogers JM, Hook CC, Havyer RD. Medicine's Valuing of "Normal" Cognitive Ability. AMA J Ethics. 2015 Aug; 17: (8)717-26.
    View PubMed
  34. Topazian RJ, Hook CC, Mueller PS. Duty to speak up in the health care setting a professionalism and ethics analysis. Minn Med. 2013 Nov; 96(11):40-3.
    View PubMed
  35. Lim MY, Al-Kali A, Ashrani AA, Begna KH, Elliott MA, Hogan WJ, Hook CC, Kaufmann SH, Letendre L, Litzow MR, Patnaik MS, Pardanani A, Tefferi A, Wolanskyj AP, Grill DE, Pruthi RK. Comparison of complication rates of Hickman((R)) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Lymphoma. 2013 Jun; 54 (6):1263-7 Epub 2012 Nov 19
    View PubMed
  36. Hook CC, Swetz KM, Mueller PS. Ethics committees and consultants. Handb Clin Neurol. 2013; 118:25-34.
    View PubMed
  37. Burkle CM, Mueller PS, Swetz KM, Hook CC, Keegan MT. Physician perspectives and compliance with patient advance directives: the role external factors play on physician decision making. BMC Med Ethics. 2012 Nov 21; 13:31
    View PubMed
  38. Zacharias DG, Nelson TJ, Mueller PS, Hook CC. Impedance of novel therapeutic technologies: the case of stem cells. Clin Transl Sci. 2012 Oct; 5(5):422-7. Epub 2012 Jun 28.
    View PubMed
  39. Elliott MA, Letendre L, Tefferi A, Hogan WJ, Hook C, Kaufmann SH, Pruthi RK, Pardanani A, Begna KH, Ashrani AA, Wolanskyj AP, Al-Kali A, Litzow MR. Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy. Eur J Haematol. 2012 Mar; 88(3):237-43. Epub 2011 Nov 17.
    View PubMed
  40. Zacharias DG, Nelson TJ, Mueller PS, Hook CC. The science and ethics of induced pluripotency: what will become of embryonic stem cells? Mayo Clin Proc. 2011 Jul; 86 (7):634-40
    View PubMed
  41. Hook CC. In vitro fertilization and stem cell harvesting from human embryos: the law and practice in the United States. Pol Arch Med Wewn. 2010 Jul; 120: (7-8)282-9.
    View PubMed
  42. Mueller PS, Litin SC, Hook CC, Creagan ET, Cha SS, Beckman TJ. A novel advance directives course provides a transformative learning experience for medical students. Teach Learn Med. 2010 Apr; 22(2):137-41.
    View PubMed
  43. Antiel RM, Curlin FA, Hook CC, Tilburt J. Oaths and other Professional Codes of Ethics: Results of a National Physician Survey. Archives in Internal Medicine. 2010; in press).
  44. Elliott MA, Heit JA, Pruthi RK, Gastineau DA, Winters JL, Hook CC. Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature. Eur J Haematol. 2009 Oct; 83 (4):365-72 Epub 2009 June 08
    View PubMed
  45. Mueller PS, Case EJ, Hook CC. Responding to offers of altruistic living unrelated kidney donation by group associations: an ethical analysis. Transplant Rev (Orlando). 2008 Jul; 22: (3)200-5.
    View PubMed
  46. Mrazek M, Koenig B, Skime M, Snyder K, Hook C, Black J 3rd, Mrazek D. Assessing attitudes about genetic testing as a component of continuing medical education. Acad Psychiatry. 2007 Nov-Dec; 31: (6)447-51.
    View PubMed
  47. Swetz KM, Crowley ME, Hook C, Mueller PS. Report of 255 clinical ethics consultations and review of the literature. Mayo Clin Proc. 2007 Jun; 82 (6):686-91
    View PubMed
  48. Mueller PS, Hook CC, Litin SC. Physician preferences and attitudes regarding industry support of CME programs. Am J Med. 2007 Mar; 120(3):281-5.
    View PubMed
  49. Behl D, Porrata LF, Markovic SN, Letendre L, Pruthi RK, Hook CC, Tefferi A, Elliot MA, Kaufmann SH, Mesa RA, Litzow MR. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia. 2006 Jan; 20(1):29-34.
    View PubMed
  50. Hook CC, Mueller PS. The Terri Schiavo saga: the making of a tragedy and lessons learned. Mayo Clin Proc. 2005 Nov; 80(11):1449-60.
    View PubMed
  51. Elliott MA, Wolf RC, Hook CC, Pruthi RK, Heit JA, Letendre LL, Tefferi A, Kaufmann SH, Mesa RA, Litzow MR. Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombin. Leuk Lymphoma. 2004 Aug; 45 (8):1545-9
    View PubMed
  52. Hook CC, DiMagno EP, Tefferi A. Primer on medical genomics. Part XIII: Ethical and regulatory issues. Mayo Clin Proc. 2004 May; 79 (5):645-50
    View PubMed
  53. Mueller PS, Hook CC, Fleming KC. Ethical issues in geriatrics: a guide for clinicians. Mayo Clin Proc. 2004 Apr; 79 (4):554-62
    View PubMed
  54. Mueller PS, Hook CC, Hayes DL. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clin Proc. 2003 Aug; 78(8):959-63.
    View PubMed
  55. Steensma DP, Hook CC, Stafford SL, Tefferi A. Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia. Br J Haematol. 2002 Sep; 118 (3):813-6
    View PubMed
  56. Elliott MA, Mesa RA, Li CY, Hook CC, Ansell SM, Levitt RM, Geyer SM, Tefferi A. Thalidomide treatment in myelofibrosis with myeloid metaplasia. Br J Haematol. 2002 May; 117 (2):288-96
    View PubMed
  57. Mesa RA, Tefferi A, Elliott MA, Hoagland HC, Call TG, Schroeder GS, Yoon SY, Li CY, Gray LA, Margolin S, Hook CC. A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia. Br J Haematol. 2001 Jul; 114 (1):111-3
    View PubMed
  58. Tefferi A, Elliott MA, Steensma DP, Hook CC, Dispenzieria A, Hanson CA, Schroeder G, Letendre L. Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome. Leuk Res. 2001 Feb; 25 (2):183-5
    View PubMed
  59. Orr RD, Hook CC. Stem cell research: magical promise v. moral peril. Yale Journal of Health Policy Law and Ethics. 2001; 2:189-99.
  60. Porrata LF, Alberts S, Alberts S, Hook C, Hanson CA. Idiopathic thrombocytopenic purpura associated with breast cancer: a case report and review of the current literature. Am J Clin Oncol. 1999 Aug; 22 (4):411-3
    View PubMed
  61. Hook CC, Koch KA. Ethics of resuscitation. Crit Care Clin. 1996 Jan; 12 (1):135-48
    View PubMed
  62. Menke DM, Greipp PR, Colon-Otero G, Solberg LA Jr, Cockerill KJ, Hook CC, Witzig TE. Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders. Arch Pathol Lab Med. 1994 Aug; 118(8):811-4.
    View PubMed
  63. Lee TC, Hook CC, Long HJ. Severe exfoliative dermatitis associated with hand ischemia during cisplatin therapy. Mayo Clin Proc. 1994 Jan; 69 (1):80-2
    View PubMed
  64. Schild SE, Scheithauer BW, Schomberg PJ, Hook CC, Kelly PJ, Frick L, Robinow JS, Buskirk SJ. Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects. Cancer. 1993 Aug 1; 72 (3):870-80
    View PubMed
  65. Colon-Otero G, Menke D, Menke D, Hook CC. A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia. Med Clin North Am. 1992 May; 76 (3):581-97
    View PubMed
  66. Hook CC, Kimmel DW, Kvols LK, Scheithauer BW, Forsyth PA, Rubin J, Moertel CG, Rodriguez M. Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol. 1992 Mar; 31(3):262-7.
    View PubMed